1.In vivo characterization of the integrin beta3 as a receptor for Hantaan virus cellular entry.
Jin Won SONG ; Ki Joon SONG ; Luck Ju BAEK ; Blasie FROST ; Mortimer PONCZ ; Kwang Sook PARK
Experimental & Molecular Medicine 2005;37(2):121-127
Binding of viruses to cell surface molecules is an essential step in viral infection. In vitro studies suggested that the alpha v beta3 integrin receptor is the epithelial cell receptor for Hantaan virus (HTNV). Whether beta3 is in vivo the only or central cellular receptor for HTNV infection is not known. To investigate the role of beta3 integrin for cellular entry of HTNV, we established an HTNV infection model in newborn murine pups. Infected pups died at an average age of 14.2 +/- 1.1 days with high levels of viral antigen detected in their brain, lung, and kidney. Pre-injection of blocking monoclonal antibodies (mAb) specific for either beta3 or av prolonged survival significantly to a maximal average survival of 19.7 +/- 1.5 days (P<0.01) and 18.4 +/- 0.9 days (P<0.01), respectively. XT-199, a chemical blocker of the alpha v beta3 receptor also prolonged survival to 19.5 +/- 1.3 days (P<0.01). In contrast to these receptor blockades, anti-HTNV antibody was not only able to prolong survival, but 20% of infected pups achieved long-term survival. An anti-murine beta1 antibody comparatively prolonged survival (19.0 +/- 1.2 days), suggesting that HTNV infection is partly mediated through integrin beta1 receptors as well as through beta3 receptors in vivo. Our data demonstrate that the beta3 receptor is important for HTNV infection in vivo, but also suggest that HTNV may utilize additional receptors beyond beta3 for cellular entry within an organism.
Animals
;
Animals, Newborn
;
Antibodies, Monoclonal/therapeutic use
;
Antigens, CD29/metabolism
;
Hantaan virus/*metabolism/pathogenicity
;
Hemorrhagic Fever with Renal Syndrome/mortality/*virology
;
Imidazoles/pharmacology
;
Integrin alphaV/metabolism
;
Integrin alphaVbeta3/antagonists & inhibitors
;
Integrin beta3/*metabolism
;
Mice
;
Receptors, Virus/*metabolism
;
Research Support, N.I.H., Extramural
;
Research Support, Non-U.S. Gov't
;
Research Support, U.S. Gov't, P.H.S.
2.Evidence that the fully assembled capsid of Leishmania RNA virus 1-4 possesses catalytically active endoribonuclease activity.
Young Tae RO ; Eun Ju KIM ; Hyun Il LEE ; Margarita SAIZ ; Ricardo Carrion JR ; Jean L PATTERSON
Experimental & Molecular Medicine 2004;36(2):145-156
In this study, Leishmania RNA virus 1-4 (LRV1-4) particles purified from host Leishmania guyanensis promastigotes were examined for capsid endoribonuclease. Temperature optimum for the endoribonulease activity was found to be at 37degrees C to 42degrees C and the activity was specifically inhibited by the aminoglycoside antibiotics, neomycin, kanamycin, and hygromycin and by 100 mM levels of NaCl or KCl. To determine the catalytic domain of the capsid endoribonuclease activity, three point-mutation at cysteine residues at C47S (P1), C128/ 133S (P2), and C194R (P3) were prepared and each gene was constructed into baculoviruses and expressed in Sf9 insect cells. LRV1-4 capsid N- terminus (N2 and N3) and C-terminus (C1 and C2) deletion mutants (Cadd et al., 1994) were also examined by in vitro RNA cleavage assay. The results showed that the capsid mutants; C1, C2, N3, P1, and P2 were capable of forming proper virus-like particles (VLPs) and they all possessed the specific endoribonuclease activity. However, two assembly-defective capsid mutants, N2 (N- terminus 24-amino acids deletion) and P3 mutants, did not retain the specific endoribonuclease activity. Taken together, the results suggest that at least 24 amino acids from the N-terminal region and C194 residue in LRV1-4 capsid protein are functionally important for LRV1-4 viral assembly and the capsid endoribonuclease activity may be dependent upon the properly assembled LRV1-4 virus particles.
Amino Acid Substitution
;
Animals
;
Anti-Bacterial Agents/pharmacology
;
Baculoviridae
;
Capsid/*enzymology
;
Cell Line
;
Cysteine/genetics
;
Endoribonucleases/antagonists & inhibitors/chemistry/genetics/isolation & purification/*metabolism
;
Enzyme Activation/drug effects
;
Heat
;
Insects
;
Leishmania guyanensis/*virology
;
RNA/chemistry
;
RNA Viruses/*enzymology/genetics
;
Recombinant Proteins/antagonists & inhibitors/genetics/isolation & purification/metabolism
;
Research Support, Non-U.S. Gov't
;
Research Support, U.S. Gov't, P.H.S.
;
Substrate Specificity/genetics
;
Transduction, Genetic
3.Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis.
Hyo Won JUNG ; Seung Won CHOI ; Jung IL CHOI ; Byoung Se KWON
Experimental & Molecular Medicine 2004;36(1):13-22
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease whose etiopathogenesis is not well understood. Although soluble (s) forms of 4-1BB (s4-1BB) and 4-1BB legand (s4-1BBL) have been detected in the sera of RA patients, their significance is not known. We compared the serum levels of s4-1BB and s4-1BBL in RA patients with those in systemic lupus erythematosus (SLE) and Behcet's disease (BD) patients. Serum levels of s4-1BB and s4-1BBL were significantly higher in RA patients compared with healthy controls, SLE or BD patients, and the abundance was correlated with disease severity in patients with RA. The serum levels of s4-1BB in RA patients were inversely corroborated with 4-1BB expression levels on activated T lymphocytes. In addition, there was a correlation between serum levels of s4-1BB and s4-1BBL. The augmented secretion of s4-1BB and s4-1BBL levels into the serum may reflect the clinical symptoms of RA and levels of s4-1BB and s4-1BBL in sera at the time of diagnosis may be indicative of the severity and outcome of RA.
Adult
;
Aged
;
Antigens, CD/metabolism
;
Arthritis, Rheumatoid/*blood/drug therapy/immunology/*pathology
;
Behcet Syndrome/blood/immunology
;
Comparative Study
;
Female
;
Humans
;
Immunosuppressive Agents/metabolism/therapeutic use
;
Leukocytes, Mononuclear/metabolism
;
Lupus Erythematosus, Systemic/blood/immunology
;
Male
;
Middle Aged
;
Random Allocation
;
Receptors, Nerve Growth Factor/*blood
;
Receptors, Tumor Necrosis Factor/*blood
;
Research Support, Non-U.S. Gov't
;
Research Support, U.S. Gov't, P.H.S.
;
Severity of Illness Index
;
Statistics
;
Tumor Necrosis Factor-alpha/*metabolism
4.Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm.
David C PAIK ; Chenzhong FU ; Jahar BHATTACHARYA ; M DAVID TILSON
Experimental & Molecular Medicine 2004;36(6):524-533
Pathogenesis of the abdominal aortic aneurysm has been attributed to neovascularization of the aortic wall. However, it is not clear whether angiogenesis persists in the aneurysm. In sections of aneurysms, we determined the immunohistochemical distributions of the alpha v beta 3 integrin, tenascin and endothelial nitric oxide synthase (eNOS), which are markers respectively, of angiogenesis, matrix remodeling and vasoregulatory function. In addition, we used reverse transcription followed by in situ PCR, to determine the distribution of alpha v mRNA. All aneurysm specimens exhibited extensive increases of wall vascularization as compared with the control aortic wall, and showed the presence of perivascular inflammatory exudates containing macrophages and lymphocytes. The neovascularization consisted of thick-walled vessels in the media and adventitia, and capillaries in the subintima. The majority of vessels stained positively for the alpha v beta 3 antigen and eNOS. Tenascin was deposited as bands that circumscribed thick-walled vessels. The distribution of av mRNA was extensive and was positive even in those vessels that failed to stain for the alpha v beta 3 protein. No staining was evident in control aortas for the alpha v beta 3 antigen, tenascin or alpha v mRNA. The upregulation of av mRNA and the alpha v beta 3 integrin in blood vessels surrounded by a matrix expressing tenascin, indicates that angiogenesis is an ongoing process in the mature aortic aneurysm.
Adult
;
Aorta, Abdominal/immunology/pathology
;
Aortic Aneurysm, Abdominal/*pathology
;
Biological Markers/analysis/metabolism
;
Female
;
Humans
;
Integrin alphaVbeta3/analysis/genetics/metabolism
;
Male
;
Neovascularization, Pathologic/genetics/*metabolism
;
Nitric-Oxide Synthase/analysis/metabolism
;
RNA, Messenger/analysis/metabolism
;
Research Support, N.I.H., Extramural
;
Research Support, U.S. Gov't, P.H.S.
;
Tenascin/analysis/metabolism
5.The Effects of Intradermal Vaccination with DNA Encoding for the T-cell Receptor on the Induction of Experimental Autoimmune Encephalomyelitis in B10.PL Mice.
Soon Seog KWON ; Nachsung KIM ; Tae June YOO
Journal of Korean Medical Science 2005;20(6):1039-1045
Intradermal gene administration was found to induce a more profound immune response than direct intramusclular gene injection. We performed intradermal vaccination of B10.PL mice with DNA encoding for the V 8.2 region of the T-cell receptors (TCR). Three weeks later, these mice were immunized with rat myelin basic protein (MBP). Daily mean clinical scores and mortality rate were lower in this group compared with controls. The proliferative responses of lymph node cells to rat MBP were slightly less in the vaccination groups than in the control groups (p<0.05). However, we detected no differences between the two groups with regard to the production of MBP-specific IgG, IgG1, & IgG2a antibodies. The levels of cytokine mRNA expression in the vaccination groups were observed higher than in the control groups without antigen-specific stimulation, but all of cytokine expressions between the vaccination and control groups after antigen-specific stimulation were identical. These results demonstrate that intradermal DNA vaccines encoding for TCR might prove to be useful in the control of autoimmune disease.
Animals
;
Autoantibodies/blood
;
Base Sequence
;
Cytokines/genetics
;
DNA, Complementary/genetics
;
Encephalomyelitis, Autoimmune, Experimental/etiology/immunology/*prevention and control
;
Female
;
Gene Expression
;
*Genes, T-Cell Receptor beta
;
In Vitro
;
Injections, Intradermal
;
Lymphocyte Activation
;
Mice
;
Myelin Basic Proteins/immunology
;
RNA, Messenger/genetics/metabolism
;
Rats
;
Research Support, N.I.H., Extramural
;
Research Support, Non-U.S. Gov't
;
Vaccines, DNA/*administration and dosage/genetics
6.The Medical Science Research and Development Supported by the Korea Science and Engineering Foundation.
Tae Sun MIN ; Jin HAN ; Seong Yong KIM ; Byoung Doo RHEE ; Myung Suk KIM
Journal of Korean Medical Science 2005;20(3):345-354
This study examined ways of promoting research in the medical sciences by evaluating trends in research funding, and the present status of research funding by the Korea Science and Engineering Foundation (KOSEF). This study analyzed statistics from KOSEF from 1978 to 2003 to examine support for research. In medical science field, group-based programs receive more funding than do individual-based programs. The proportion of research funds allocated to the medical sciences has increased markedly each year. Researchers in the medical sciences have submitted more articles to Science Citation Index (SCI) journals than to non-SCI journals, relative to other fields. Researchers supported by the Mission-Oriented Basic Grants program have published the majority of these papers, followed by those supported by the Programs for Leading Scientists, Regional Scientists, Leading Women Scientists, Young Scientists, and Promising Women Scientists, in that order. Funding by KOSEF reflects many decades of government support for research and development, the development and maintenance of necessary infrastructure, and the education and training of medical scientists.
Biomedical Research/*economics
;
Foundations/*economics/statistics & numerical data
;
Humans
;
Korea
;
Research Support/*economics/trends
;
Research Support, Non-U.S. Gov't
;
Science
7.Regulatory T Cells - An Emerging Role in Transplantation.
Yonsei Medical Journal 2004;45(6):968-977
No abstract available.
Animals
;
Humans
;
*Organ Transplantation
;
Research Support, Non-U.S. Gov't
;
T-Lymphocytes/*immunology
;
*Transplantation Immunology
8.Analysis of Loss of Heterozygosity in Korean Patients with Keratoacanthoma.
Tae Won HA ; Ki Hwan HAN ; Dae Gu SON ; Sang Pyo KIM ; Dae Kwang KIM
Journal of Korean Medical Science 2005;20(2):340-343
Loss of heterozygosity (LOH) has been established as an important genetic mechanism giving rise to malignant neoplasia. The mechanism of LOH has been shown to cause basal cell carcinoma and malignant melanoma as well as other types of skin cancer. A few studies on LOH in sporadic keratoacanthomas have been reported. The purpose of this study was to investigate the significance of LOH in the pathogenesis of sporadic keratoacanthomas developed in 10 Korean patients. The presents of LOH at 7 microsatellite markers (D2S286, D3S1317, D5S346, D9S160, D9S171, D10S185, and D17S261) were evaluated in sporadic keratoacanthomas. LOH was found in only 1 of 10 cases at D10S185. The low frequency of LOH detected in this study suggests that LOH may not be significant in the induction of sporadic keratoacanthomas.
Adult
;
Aged
;
Female
;
Humans
;
Keratoacanthoma/*genetics
;
*Loss of Heterozygosity
;
Male
;
Middle Aged
;
Research Support, Non-U.S. Gov't
9.Multiple Imputation Technique Applied to Appropriateness Ratings in Cataract Surgery.
Yoon Jung CHOI ; Chung Mo NAM ; Min Jung KWAK
Yonsei Medical Journal 2004;45(5):829-837
Missing data such as appropriateness ratings in clinical research are a common problem and this often yields a biased result. This paper aims to introduce the multiple imputation method to handle missing data in clinical research and to suggest that the multiple imputation technique can give more accurate estimates than those of a complete-case analysis. The idea of multiple imputation is that each missing value is replaced with more than one plausible value. The appropriateness method was developed as a pragmatic solution to problem of trying to assess "appropriate" surgical and medical procedures for patients. Cataract surgery was selected as one of four procedures that were evaluated as a part of the Clinical Appropriateness Initiative. We created mild to high missing rates of 10%, 30% and 50% and compared the performance of logistic regression in cataract surgery. We treated the coefficients in the original data as true parameters and compared them with the other results. In the mild missing rate (10%), the deviation from the true coefficients was quite small and ignorable. After removing the missing data, the complete-case analysis did not reveal any serious bias. However, as the missing rate increased, the bias was not ignorable and it distorted the result. This simulation study suggests that a multiple imputation technique can give more accurate estimates than those of a complete-case analysis, especially for moderate to high missing rates (30 - 50%). In addition, the multiple imputation technique yields better accuracy than a single imputation technique. Therefore, multiple imputation is useful and efficient for a situation in clinical research where there is large amounts of missing data.
Cataract Extraction/*methods
;
Humans
;
Logistic Models
;
Research Support, Non-U.S. Gov't
10.Chondrogenic Differentiation of Mesenchymal Stem Cells and Its Clinical Applications.
Jin Woo LEE ; Yun Hee KIM ; Su Hyang KIM ; Seung Hwan HAN ; Soo Bong HAHN
Yonsei Medical Journal 2004;45(Suppl):S41-S47
Tissue engineering has the potential to provide cartilaginous constructs capable of restoring the normal function of native articular cartilage following joint injury or degradation. One approach to functional tissue engineering of cartilage involves the in vitro cultivation of tissue constructs by using: (i) chondrogenic cells that can be selected, expanded, and transfected to overexpress the genes of interest, (ii) scaffolds that provide a defined three-dimensional structure for tissue development and biodegrade at a controlled rate. Understanding the functional potential of the cells and the signaling mechanisms underlying their differentiation should lead to innovative protocols for clinical orthopaedic interventions. A large number of growth factors and hormones have been implicated in the regulation of chondrocyte biology, relatively little is known about the intracellular signaling pathways involved. We have tried to define the roles of specific TGF-betadependent signaling pathways involved in the regulation of chondrogenesis from human mesenchymal stem cells. Chondrogenesis induced by TGF-beta in alginate bead system was confirmed by examining cartilage specific type II collagen expression and aggrecan, whereas type I collagen expression was not affected by TGF-beta. Type II collagen mRNA expression was expressed strongly during chondrogenesis and MEK inhibition (U0126) resulted in complete down-regulation of type II collagen. In contrast, aggrecan expression was detected in same level by treatment of U0126. These results strongly suggest that the ERK signaling cascade is involved in TGF-beta induced-chondrogenesis signaling pathways and a role of its pathway is necessary over a longer period to promote type II collagen expression. However, their end product properties in vivo have not been well known. In this study, an articular cartilage from chondrogenic MSCs with PLGA scaffolds (75:25 and 65:35) were made and analyzed its biochemical, histological and mechanical properties in vitro and in vivo. And also, we evaluated the cartilage formation in vivo through the injection of cell-thermosensitive gel complex, a newly developed injectable material. At 12 weeks after PLGA scaffolds containing chondrogenic MSCs transplantation, the separated rabbit distal femur showed a good gross articular cartilage appearance in the transplanted site. In indentation test, compare to the native articular cartilage, the engineered cartilage from two types of (75:25 and 65:35) achieved up to 30-60% in mechanical stiffness. And also, a new model for cartilage formation in bladder, at 14 weeks after injection, we could find out mass formation in the submucosal area grossly. H&E staining, alcian blue staining and other special staining confirmed the chondrogenic differentiation in the mass. These cell therapy technologies can provide the possibility of clinical applications for vesicoureteral reflux and reflux esophagitis, and urinary incontinence as well as articular cartilage regeneration.
Animals
;
Cell Differentiation
;
Chondrocytes/*cytology
;
Humans
;
Mesenchymal Stem Cells/*cytology
;
Research Support, Non-U.S. Gov't
;
*Tissue Engineering